Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Purple Biotech Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q4 2022
- Shares held
- 125.2K
- −48.5K (−27.9%) vs. Q4 2022
- Total value
- $224.2K
- −$14.3K (−6.0%) vs. Q4 2022
- New holders
- 5
- 1 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 23,088 | $41.3K | 0.00% | +1,218+5.6% | Added |
| Simplex Trading, LLC | 19,703 | $34.0K | 0.00% | +19,703 | New |
| Citadel Advisors LLC | 15,175 | $26.7K | 0.00% | −30,690−66.9% | Reduced |
| Venture Visionary Partners LLC | 13,068 | $23.4K | 0.00% | 00.0% | Unchanged |
| Wealth Advisors of Iowa, LLC | 12,505 | $22.4K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,666 | $22.3K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 11,000 | $19.7K | 0.00% | +11,000 | New |
| TD Waterhouse Canada Inc. | 4,000 | $9.58K | 0.00% | +4,000 | New |
| UBS Group AG | 4,566 | $8.17K | 0.00% | −3,723−44.9% | Reduced |
| Group One Trading, L.P. | 3,371 | $5.93K | 0.00% | −830−19.8% | Reduced |
| Belpointe Asset Management LLC | 2,600 | $4.65K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 1,995 | $3.57K | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 1,000 | $1.90K | 0.00% | +1,000 | New |
| North Star Investment Management Corp. | 300 | $537 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $90 | 0.00% | +50 | New |
| Royal Bank of Canada | 108 | $0 | 0.00% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 0 | $0 | 0.00% | −32,200−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −14,719−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −3,250−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |